Join HTG at the ASCO-SITC meeting to learn how we are enabling drug development from discovery to clinic with our universal CDx NGS-based multiplexed profiling panels, extraction-free NGS-based chemistry and our NGS-based automation, the HTG EdgeSeq system.
Thursday, February 23 - Saturday, February 25, 2017
Hyatt Regency Orlando
This no-fee Symposium brings together key molecular and pharma professionals for the opportunity to network, discuss noteworthy and trending topics and exchange information in the fields of immuno-oncology and companion diagnostics.
Who should attend?
- Thought leaders who look forward to sharing new ideas and solid science that will move pathology and oncology forward.
- Pathologists who strive to keep their practice on the leading edge with the newest knowledge and technologies.
- Translational or clinical development within pharma.
- Next-Generation Immuno-Oncology Therapeutics
- Emerging Biomarkers
- New Applications of Gene Expression Profiling for Clinical Testing
- New Treatment Strategies
Monday, March 20, 2017 - Dinner
Tuesday, March 21, 2017 - Symposium
Hotel Marriott Rive Gauche
Tuesday, March 21, 2017
Dr. Pierre Saintignym, Center Léon Bérard, France
Integrating The Immune Microenvironment And Cancer Cell Plasticity In The Era Of Precision Medicine In Oncology
Dr. Peter Wild, Institute of Pathology and Molecular Pathology, University of Zürich, Switzerland
MicroRNAs In Serum Of Patients With Testicular Germ Cell Tumors Using A Novel Targeted Multiplex Sequencing Assay
Dr. Patrick Micke, Department of Pathology, Uppsala University Hospital, Sweden
Beyond Targeted Therapy: The Immune Landscape Of Human Lung Cancer
Dr. Jose Antonio Lopez, Instituto Valenciano de Oncología, Spain
The Role Of The HTG Edgeseq System In mRNA Pro ling For Therapeutic Decision Making: The Soft Tissue Sarcoma And Breast Cancer Scenarios
Sample To Insight: The Complete Clinical NGS Work ow
Dr. Carsten Denkert, Institut für Pathologie, Charite Hospital, Germany
mRNA Biomarker In FFPE Tissue – New Approaches To Immuno Oncology In Breast Cancer
Dr. Lakis Liloglou, University of Liverpook, UK
Epigenetic Pro ling Of Extracellular Vesicles (EVS) In Early Diagnosis Of Lung Cancer
Dr. Sharon Barrans, The Leeds Teaching Hospital, UK
Molecular Classi cation Of Aggressive Lymphomas
Join HTG at the Global Congress on Molecular Pathology (AMP Global) 2017 meeting to learn how our collaborators are innovating next-generation pathology with the NGS-based HTG EdgeSeq system and assays.
Monday, April 3 - Wednesday, April 5, 2017
Congress & Exhibition Center
Join HTG at the 2017 AACR Annual Meeting and learn more about our NGS-based sequencing assays that are automated on the HTG EdgeSeq system.
Saturday, May 27 - Tuesday, May 30, 2017